Vestmark Advisory Solutions’s Bio-Rad Laboratories Class A BIO Stock Holding History

Vestmark Advisory Solutions’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-421	Closed	-$202K	–	881
2023 Q1	$202K	Buy	+421	New	+$197K	0.01%	826
2022 Q2	–	Sell	-547	Closed	-$308K	–	850
2022 Q1	$308K	Buy	547 +107	+24%	+$64.5K	0.02%	708
2021 Q4	$332K	Buy	440 +13	+3%	+$9.73K	0.02%	675
2021 Q3	$319K	Buy	+427	New	+$320K	0.02%	642
2020 Q3	–	Sell	-751	Closed	-$339K	–	547
2020 Q2	$339K	Sell	751 -155	-17%	-$68.4K	0.05%	378
2020 Q1	$318K	Buy	+906	New	+$333K	0.06%	349
2019 Q4	–	Sell	-1,006	Closed	-$335K	–	281
2019 Q3	$335K	Sell	1,006 -1	-0.1%	-$326	0.05%	386
2019 Q2	$315K	Sell	1,007 -47	-4%	-$14.1K	0.05%	392
2019 Q1	$322K	Buy	+1,054	New	+$284K	0.06%	378

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Vestmark Advisory Solutions's BIO Position: Q2 2023 in Review

Vestmark Advisory Solutions sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2023, closing a stake of 421 shares — an estimated $202K sold.

Vestmark Advisory Solutions first reported a position in BIO in Q1 2019 and held it in 9 quarters. The position peaked at $339K in Q2 2020. 469 funds tracked by Wall St. Rank hold BIO as of Q2 2023.

Vestmark Advisory Solutions reported no remaining Bio-Rad Laboratories Class A position as of Q2 2023 after selling out during the quarter.
Vestmark Advisory Solutions sold 421 Bio-Rad Laboratories Class A shares in Q2 2023, an estimated $202K.
Vestmark Advisory Solutions first reported a position in Bio-Rad Laboratories Class A in Q1 2019 and held it in 9 quarters.
Vestmark Advisory Solutions's Bio-Rad Laboratories Class A position peaked at $339K in Q2 2020.
469 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2023.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2023, filed 7 Aug 2023.